Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ovid Therapeutics

Ovid Therapeutics
2014 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
OVID STOCK SYMBOL
$2.56 SHARE PRICE (As of Monday Closing)
Description

Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is engaged primarily in developing impactful medicines for patients and families living who are suffering with rare neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 1460 Broadway
  • Suite 15021
  • New York, NY 10036
  • United States

+1 (646) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ovid Therapeutics’s full profile, request a free trial.

Ovid Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.53 - $5.67 $122M $2.55 -$1.73 620K 47.8M

Ovid Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 73,915 7,155 146,792
Revenue 0 0 0 0
EBITDA (57,011) (52,790) (64,927) (22,479)
Net Income (56,392) (51,980) (64,806) (22,414)
Total Assets 40,694 47,650 89,458 53,028
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ovid Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ovid Therapeutics‘s full profile, request access.

Request full access to PitchBook

Ovid Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Ovid Therapeutics‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Ovid Therapeutics Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Minerva Neurosciences Formerly VC-backed Waltham, MA 00 00000 00000000 00000
00000000 000000000 Formerly VC-backed Coral Gables, FL 00 000.00 00000000 000.00
0000000000 0000000 Formerly VC-backed Toronto, Canada 00 000.00 000000&0 000.00
000000000 Venture Capital-Backed New York, NY 000.00 00000000000 000.00
0000000 Venture Capital-Backed CA 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Ovid Therapeutics Executive Team (13)

Name Title Board
Seat
Contact
Info
Jeremy Levin Ph.D Chief Executive Officer & Chairman
Matthew During MD Chief Financial Officer & Chief Accounting Officer
Timothy Daly Controller & Senior Vice President
Amit Rakhit MD Chief Medical Officer & Executive
Dirk Haasner Ph.D Senior Vice President

5 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

Ovid Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Bart Friedman JD Self Board Member 000 0000
Douglas Williams Ph.D Self Board Member 000 0000
Howard Federoff Ph.D Ovid Therapeutics Chairman, Scientific Advisory Board 000 0000
Jeremy Levin Ph.D Ovid Therapeutics Chief Executive Officer & Chairman 000 0000
Karen Bernstein Ph.D Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »